Medexus Pharmaceuticals Inc.
MEDXF
$2.24
-$0.031-1.37%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -553.00K | 733.00K | 110.00K | 1.96M | 762.00K |
| Total Depreciation and Amortization | 2.44M | 1.76M | 1.58M | 1.41M | 1.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -226.00K | 2.93M | 3.62M | 2.44M | 1.04M |
| Change in Net Operating Assets | 619.00K | 1.29M | 1.55M | 2.38M | -1.65M |
| Cash from Operations | 2.28M | 6.71M | 6.86M | 8.19M | 1.61M |
| Capital Expenditure | -53.00K | -61.00K | -37.00K | -32.00K | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -2.01M | -375.00K | -445.00K | -445.00K | -320.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -43.00K | -2.50M | -- | -216.00K |
| Cash from Investing | -2.06M | -479.00K | -2.98M | -477.00K | -538.00K |
| Total Debt Issued | -- | -- | -- | -- | 17.58M |
| Total Debt Repaid | -3.36M | -3.36M | -4.16M | -3.36M | -2.70M |
| Issuance of Common Stock | 19.30M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -17.58M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -779.00K | -1.10M | -1.25M | -1.14M | -1.27M |
| Cash from Financing | 15.17M | -4.46M | -5.41M | -4.50M | -3.96M |
| Foreign Exchange rate Adjustments | 153.00K | -302.00K | 60.00K | -22.00K | -67.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.53M | 1.47M | -1.48M | 3.20M | -2.96M |